{"id":"inactive-placebo-oral-capsule","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2108778","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"A placebo is an inert substance used as a control in clinical trials to establish baseline efficacy and safety by comparison with active treatments. Any observed effects are attributed to the placebo effect—psychological and physiological responses to the act of treatment rather than the substance itself. Placebos are essential for blinded study designs to isolate true drug efficacy from expectation-driven outcomes.","oneSentence":"An inactive placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:48:33.279Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clinical trial control / comparator (not a therapeutic indication)"}]},"trialDetails":[{"nctId":"NCT07496502","phase":"PHASE1, PHASE2","title":"Effect of Oral Microbiota on MDRO Decolonization","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2022-03-31","conditions":"Clostridioides Difficile Infection, Drug Resistance, Bacterial, Gastrointestinal Microbiome","enrollment":42},{"nctId":"NCT07495592","phase":"NA","title":"The Acute Effects of Onnit Alpha Brain on Cognition and Mood States","status":"NOT_YET_RECRUITING","sponsor":"Applied Science & Performance Institute","startDate":"2026-04-16","conditions":"Cognitive, Mood and Cognitive Performance, Sleep Deprivation","enrollment":34},{"nctId":"NCT06944145","phase":"PHASE2","title":"New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2025-12-03","conditions":"BPH (Benign Prostatic Hyperplasia), Lower Urinary Track Symptoms","enrollment":242},{"nctId":"NCT04924166","phase":"PHASE2","title":"PTSD Prevention Using Oral Hydrocortisone","status":"COMPLETED","sponsor":"Rachel Yehuda","startDate":"2022-01-12","conditions":"PTSD, Acute Stress Disorder, Trauma-related Stressor","enrollment":201},{"nctId":"NCT07267559","phase":"PHASE4","title":"Dual Orexin Antagonism and Emotion and Affective Processing Study","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2025-10-01","conditions":"Learning, Cognitive Functioning, Emotional Processing","enrollment":62},{"nctId":"NCT07471048","phase":"NA","title":"A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis","status":"RECRUITING","sponsor":"Sirt3 LLC","startDate":"2026-03-01","conditions":"Psoriasis","enrollment":100},{"nctId":"NCT06269627","phase":"PHASE4","title":"Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder","status":"RECRUITING","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2025-05-07","conditions":"Alcohol Use Disorder","enrollment":48},{"nctId":"NCT07441096","phase":"NA","title":"Efficacy and Safety of Shatavari Root Extract for Premenstrual Syndrome in Women","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-20","conditions":"Premenstrual Syndrome, Women Health","enrollment":60},{"nctId":"NCT07441070","phase":"NA","title":"Effect of Ashwagandha Root Extract on Stress, Anxiety, and Sleep Quality in Adults Experiencing Minority Stress","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-24","conditions":"Minority Stress, Psychological Stress, Anxiety","enrollment":80},{"nctId":"NCT06450210","phase":"PHASE1","title":"Safety for Home Administration of Microdose Psilocybin Use","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-12-06","conditions":"Psychedelic Experiences","enrollment":20},{"nctId":"NCT07118839","phase":"PHASE2, PHASE3","title":"MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-15","conditions":"Post Traumatic Stress Disorder, Alcohol Use Disorder","enrollment":80},{"nctId":"NCT07101250","phase":"PHASE4","title":"Preoperative Acetazolamide","status":"RECRUITING","sponsor":"Prisma Health-Upstate","startDate":"2025-10-30","conditions":"Post Operative Pain, Laparoscopic Hysterectomy, Referred Pain","enrollment":100},{"nctId":"NCT06768944","phase":"PHASE2","title":"Subjective Experience Following Psilocybin","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2026-04","conditions":"Investigating the Importance of the Subjective Psychedelic Experience","enrollment":128},{"nctId":"NCT03652740","phase":"PHASE1","title":"Effects of Commonly Used Medications on Mood and Choice","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2018-10-02","conditions":"Healthy","enrollment":25},{"nctId":"NCT07220694","phase":"NA","title":"Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance","status":"RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-01-29","conditions":"Insulin Resistance, Mild Cognitive Impairment, Cognitive Decline","enrollment":140},{"nctId":"NCT07369115","phase":"PHASE4","title":"Neurocircuitry Mechanisms and Efficacy of Lumateperone as Adjunctive Therapy for Major Depressive Disorder and History of Early Life Abuse","status":"NOT_YET_RECRUITING","sponsor":"University of Texas at Austin","startDate":"2026-02","conditions":"Major Depressive Diorder, Early Life Trauma","enrollment":50},{"nctId":"NCT06602271","phase":"PHASE3","title":"PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)","status":"RECRUITING","sponsor":"Ensysce Biosciences","startDate":"2025-12-09","conditions":"Postoperative Pain, Acute","enrollment":320},{"nctId":"NCT01988883","phase":"EARLY_PHASE1","title":"Modafinil and Cognitive Function in POTS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2014-10","conditions":"Postural Tachycardia Syndrome","enrollment":20},{"nctId":"NCT07322679","phase":"NA","title":"Dihydroberberine Effects on Body Composition and Metabolic Health in Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"Nanjing Nutrabuilding Bio-tech Co., Ltd.","startDate":"2025-12-15","conditions":"Health Adult Subjects","enrollment":120},{"nctId":"NCT04112368","phase":"PHASE4","title":"Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2020-09-15","conditions":"Suicidal Ideation","enrollment":124},{"nctId":"NCT06349083","phase":"PHASE2","title":"Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2025-08-26","conditions":"Alcohol Use Disorder","enrollment":200},{"nctId":"NCT07269223","phase":"NA","title":"Oral Vitamin D3 Effect on Inflammatory Biomarkers in Ulcerative Colitis Patients","status":"RECRUITING","sponsor":"University of Veterinary and Animal Sciences, Lahore - Pakistan","startDate":"2025-09-02","conditions":"Ulcerative Colitis (UC)","enrollment":60},{"nctId":"NCT06308653","phase":"PHASE3","title":"Psilocybin for Major Depressive Disorder (MDD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Usona Institute","startDate":"2024-03-13","conditions":"Depressive Disorder, Major","enrollment":240},{"nctId":"NCT07275177","phase":"NA","title":"Effect of Vitamin D on Body Composition and Functionality of Older Adults","status":"COMPLETED","sponsor":"Universidad Autónoma Benito Juárez de Oaxaca","startDate":"2024-01-09","conditions":"Obesity (Disorder), Obesity, Sarcopenia","enrollment":29},{"nctId":"NCT07230587","phase":"PHASE3","title":"Butylphthalide for Long-term Efficacy in Minor Stroke Study","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-12-01","conditions":"Ischemic Stroke, Minor Stroke","enrollment":1200},{"nctId":"NCT04417257","phase":"PHASE2, PHASE3","title":"Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults","status":"TERMINATED","sponsor":"Laurent Pharmaceuticals Inc.","startDate":"2020-08-18","conditions":"COVID-19 Disease","enrollment":351},{"nctId":"NCT07215455","phase":"NA","title":"Ashwagandha Extract for Weight and Stress Management in Overweight and Obese Adults","status":"COMPLETED","sponsor":"SF Research Institute, Inc.","startDate":"2025-06-17","conditions":"Weight Management, Stress","enrollment":50},{"nctId":"NCT06274528","phase":"PHASE2","title":"DORA and LP in Alzheimer's Disease Biomarkers","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2024-03-11","conditions":"Alzheimer Disease","enrollment":201},{"nctId":"NCT07221565","phase":"PHASE1, PHASE2","title":"Quantum-Synaptic Immunotherapy Mapping Using Low-Frequency Electromagnetic Resonance and Machine Learning-Based Cytokine Forecasting","status":"ENROLLING_BY_INVITATION","sponsor":"Truway Health, Inc.","startDate":"2025-10-23","conditions":"Systemic Lupus Erythematosus, Rheumatoid Arthritis, Multiple Sclerosis","enrollment":120},{"nctId":"NCT07210684","phase":"NA","title":"Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes","status":"RECRUITING","sponsor":"Nanjing Nutrabuilding Bio-tech Co., Ltd.","startDate":"2025-08-06","conditions":"Prediabetes","enrollment":54},{"nctId":"NCT07189754","phase":"NA","title":"A Study of Sabroxy™ (Oroxylum Indicum Extract) for Improving Cognitive Function in Adults With Mild Memory Concerns","status":"COMPLETED","sponsor":"SF Research Institute, Inc.","startDate":"2020-11-02","conditions":"Mild Cognitive Impairment (MCI), Cognitive Dysfunction, Cognitive Disorder, Memory Problems","enrollment":70},{"nctId":"NCT07139964","phase":"NA","title":"High-Dose Vitamin D3 for Diabetic Foot Ulcer Healing: Randomized Controlled Trial","status":"COMPLETED","sponsor":"Universitas Sriwijaya","startDate":"2024-07-01","conditions":"Diabetic Foot Ulcer, Vitamin D Deficiency, Wound Healing Disorder","enrollment":24},{"nctId":"NCT06157177","phase":"PHASE4","title":"Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Primus Pharmaceuticals","startDate":"2023-11-15","conditions":"Sciatica Acute, Lumbar Spinal Stenosis","enrollment":50},{"nctId":"NCT06861920","phase":"PHASE4","title":"NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL)","status":"RECRUITING","sponsor":"Endeavor Health","startDate":"2025-04-07","conditions":"Dysmenorrhea, Chronic Pelvic Pain, Pelvic Pain","enrollment":600},{"nctId":"NCT03787628","phase":"PHASE2","title":"Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2022-05-19","conditions":"Opioid-use Disorder","enrollment":35},{"nctId":"NCT07033637","phase":"NA","title":"Probiotics and Active Aging: Enhancing Gut Health","status":"NOT_YET_RECRUITING","sponsor":"Jose Luis Felipe","startDate":"2025-09-01","conditions":"Gut -Microbiota, Older People, Physical Activity","enrollment":90},{"nctId":"NCT03608371","phase":"PHASE2","title":"BTRX-246040 Study in Participants With Parkinson's Disease With Motor Fluctuations","status":"COMPLETED","sponsor":"BlackThorn Therapeutics, Inc.","startDate":"2018-08-31","conditions":"Parkinson Disease, Motor Disorder","enrollment":24},{"nctId":"NCT03471117","phase":"PHASE4","title":"Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients","status":"RECRUITING","sponsor":"The University of Texas at Arlington","startDate":"2018-04-01","conditions":"Chronic Kidney Diseases","enrollment":28},{"nctId":"NCT05436652","phase":"PHASE2","title":"A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)","status":"COMPLETED","sponsor":"Sparrow Pharmaceuticals","startDate":"2022-07-22","conditions":"Polymyalgia Rheumatica","enrollment":66},{"nctId":"NCT03835117","phase":"PHASE2","title":"Effect of a Wide Spectrum Nutritional Supplement on Mitochondrial Function in Children With Autism Spectrum Disorder","status":"COMPLETED","sponsor":"Rossignol Medical Center","startDate":"2020-02-01","conditions":"Autism Spectrum Disorder","enrollment":16},{"nctId":"NCT04098302","phase":"PHASE2, PHASE3","title":"Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy","status":"COMPLETED","sponsor":"UConn Health","startDate":"2019-10-15","conditions":"Alcohol Use Disorder","enrollment":180},{"nctId":"NCT05949008","phase":"PHASE4","title":"Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2023-11-22","conditions":"NIDDM, Obesity","enrollment":150},{"nctId":"NCT06351683","phase":"PHASE2","title":"Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome","status":"RECRUITING","sponsor":"Iman Al-Naggar, PhD","startDate":"2024-04-03","conditions":"Lower Urinary Tract Symptoms, Overactive Bladder Syndrome","enrollment":50},{"nctId":"NCT06841458","phase":"NA","title":"Six-Month Single-Blind, Placebo-Controlled Study of a Dietary Supplement Supplement on Hair Growth in 45 Volunteers","status":"RECRUITING","sponsor":"Industrial Farmacéutica Cantabria, S.A.","startDate":"2024-10-07","conditions":"Androgenetic Alopecia","enrollment":45},{"nctId":"NCT05290493","phase":"PHASE2","title":"NB-001 in Children and Adolescents With 22q11 Deletion Syndrome","status":"COMPLETED","sponsor":"Nobias Therapeutics, Inc.","startDate":"2022-02-10","conditions":"22q11 Deletion Syndrome","enrollment":37},{"nctId":"NCT02966873","phase":"PHASE2","title":"Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2016-10-01","conditions":"Post Traumatic Stress Disorder (PTSD), Addiction, Alcohol Abuse","enrollment":182},{"nctId":"NCT06218056","phase":"PHASE2","title":"Cannabidiol for Reducing Cigarette Use","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2024-10-31","conditions":"Tobacco Use Disorder, Tobacco Smoking, Tobacco Dependence","enrollment":120},{"nctId":"NCT05576038","phase":"NA","title":"Tryptophan for Impaired AhR Signaling in Celiac Disease","status":"RECRUITING","sponsor":"McMaster University","startDate":"2022-12-01","conditions":"Tryptophan Metabolism Alterations, Celiac Disease","enrollment":50},{"nctId":"NCT03265288","phase":"PHASE2","title":"Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults","status":"COMPLETED","sponsor":"Laurent Pharmaceuticals Inc.","startDate":"2018-11-05","conditions":"Cystic Fibrosis","enrollment":166},{"nctId":"NCT04210986","phase":"PHASE1, PHASE2","title":"Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial","status":"COMPLETED","sponsor":"Steadman Philippon Research Institute","startDate":"2020-01-06","conditions":"Osteoarthritis, Knee","enrollment":75},{"nctId":"NCT03425539","phase":"PHASE3","title":"Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-06-21","conditions":"Fabry Disease","enrollment":118},{"nctId":"NCT04697810","phase":"PHASE2","title":"Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)","status":"RECRUITING","sponsor":"Can-Fite BioPharma","startDate":"2021-12-10","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":114},{"nctId":"NCT05215418","phase":"PHASE4","title":"A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2022-01-25","conditions":"Blood Pressure","enrollment":565},{"nctId":"NCT02965027","phase":"PHASE4","title":"Prazosin for Post-Concussive Headaches","status":"COMPLETED","sponsor":"Seattle Institute for Biomedical and Clinical Research","startDate":"2016-11-29","conditions":"Post-Traumatic Headache","enrollment":89},{"nctId":"NCT02266329","phase":"PHASE1, PHASE2","title":"Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2016-01-04","conditions":"Posttraumatic Headache, Combat Disorders, Post Concussion Syndrome","enrollment":89},{"nctId":"NCT04782856","phase":"PHASE2","title":"Energy Metabolism in Thyroidectomized Patients","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2020-10-28","conditions":"Thyroid Goiter, Hypothyroidism, Thyroid Cancer","enrollment":13},{"nctId":"NCT06121362","phase":"NA","title":"Effect of Protocatechuic Acid on Biochemical Markers of Immunity Status in Healthy Adults","status":"WITHDRAWN","sponsor":"Milton S. Hershey Medical Center","startDate":"2024-03","conditions":"Immunity","enrollment":""},{"nctId":"NCT04790812","phase":"PHASE4","title":"Preemptive Analgesia With Celecoxib for Acute Dental Pain Management","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-04-22","conditions":"Pain, Postoperative","enrollment":65},{"nctId":"NCT03221751","phase":"PHASE4","title":"Prazosin and Cerebrospinal Fluid (CSF) Biomarkers in Mild Traumatic Brain Injury (mTBI)","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2016-12-01","conditions":"Dementia","enrollment":9},{"nctId":"NCT04805879","phase":"PHASE2, PHASE3","title":"The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive Disorder","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2021-03-04","conditions":"Depression, Treatment Resistant Depression","enrollment":80},{"nctId":"NCT05909800","phase":"PHASE2","title":"Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes.","status":"UNKNOWN","sponsor":"Medical University of Warsaw","startDate":"2022-09-29","conditions":"Diabetes Mellitus, Type 1","enrollment":102},{"nctId":"NCT06088940","phase":"NA","title":"The Chemo-Gut Probiotic Trial for Cancer Survivors","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2023-11-10","conditions":"Cancer, Psychosocial Problem, Gastrointestinal Dysfunction","enrollment":66},{"nctId":"NCT04155099","phase":"PHASE2","title":"Investigational Microbiota Restoration Therapeutic for Hepatic Encephalopathy","status":"TERMINATED","sponsor":"Ochsner Health System","startDate":"2021-03-01","conditions":"Hepatic Encephalopathy, Cirrhosis, Liver","enrollment":5},{"nctId":"NCT01682083","phase":"PHASE3","title":"Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD).","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2013-01-08","conditions":"Melanoma","enrollment":870},{"nctId":"NCT05166746","phase":"PHASE2","title":"The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota","status":"UNKNOWN","sponsor":"Peter Humaidan","startDate":"2017-12-07","conditions":"Bacterial Vaginoses, Infertility, Female","enrollment":333},{"nctId":"NCT02790736","phase":"PHASE4","title":"Brief Intervention to Reduce Fear of Public Speaking","status":"TERMINATED","sponsor":"New York State Psychiatric Institute","startDate":"2016-06","conditions":"Social Anxiety Disorder","enrollment":6},{"nctId":"NCT02537210","phase":"NA","title":"Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2015-09","conditions":"Colitis, Ulcerative, Aminosalicylic Acid","enrollment":177},{"nctId":"NCT04504123","phase":"PHASE2","title":"MMP-9 Inhibition for Recalcitrant Wet AMD","status":"UNKNOWN","sponsor":"University of Iowa","startDate":"2020-11-04","conditions":"Exudative Macular Degeneration, Wet Age-related Macular Degeneration","enrollment":50},{"nctId":"NCT03736447","phase":"PHASE3","title":"Peanut Oral Immunotherapy Study of Early Intervention for Desensitization","status":"COMPLETED","sponsor":"Aimmune Therapeutics, Inc.","startDate":"2018-12-27","conditions":"Peanut Allergy","enrollment":146},{"nctId":"NCT05650112","phase":"PHASE1","title":"Safety and Tolerability of FB-001 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria","status":"UNKNOWN","sponsor":"Federation Bio Inc.","startDate":"2022-11-16","conditions":"Healthy, Enteric Hyperoxaluria","enrollment":48},{"nctId":"NCT05679037","phase":"PHASE3","title":"Role of Alpha-lipoic Acid in Diabetes Melitus Type 1","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2023-01","conditions":"Diabetes MellitusType 1","enrollment":52},{"nctId":"NCT03922945","phase":"PHASE4","title":"A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2019-05-02","conditions":"Adolescent Obesity, Obesity in Adolescence, Adolescent Overweight","enrollment":223},{"nctId":"NCT00302952","phase":"PHASE2","title":"Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2007-11-06","conditions":"Rheumatoid Arthritis","enrollment":64},{"nctId":"NCT03876717","phase":"PHASE4","title":"Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea","status":"COMPLETED","sponsor":"Lars Kristian Munck","startDate":"2018-10-25","conditions":"Bile Acid Malabsorption, Chronic Diarrhea","enrollment":255},{"nctId":"NCT04225221","phase":"PHASE2","title":"Neurobiology of Bulimia Nervosa","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-02-24","conditions":"Bulimia Nervosa","enrollment":10},{"nctId":"NCT04715763","phase":"PHASE2","title":"INvestigating TELmisartin Study","status":"TERMINATED","sponsor":"University of Hawaii","startDate":"2021-09-01","conditions":"Covid19","enrollment":24},{"nctId":"NCT05435378","phase":"EARLY_PHASE1","title":"Effect of Adjunctive Use of Vitamin B3 and B9 on Myeloperoxidase Level in the GCF of Patients With Stage I and II Periodontitis","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2022-07-01","conditions":"Periodontitis Stage I, Periodontal Diseases, Periodontal Inflammation","enrollment":30},{"nctId":"NCT04658654","phase":"PHASE2","title":"Cognitive Effects of Roflumilast in (a)MCI and Mild Dementia Patients","status":"UNKNOWN","sponsor":"Maastricht University Medical Center","startDate":"2021-11-19","conditions":"Mild Cognitive Impairment, Mild Dementia, Amnestic Mild Cognitive Disorder","enrollment":81},{"nctId":"NCT04980469","phase":"NA","title":"A Study to Explore the Effect of Vitex Negundo and Zingiber Officinale on Non-specific Chronic Low Back Pain Due to Sedentary Lifestyle","status":"COMPLETED","sponsor":"Vedic Lifesciences Pvt. Ltd.","startDate":"2021-09-25","conditions":"Low Back Pain","enrollment":72},{"nctId":"NCT02635776","phase":"PHASE3","title":"Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)","status":"COMPLETED","sponsor":"Aimmune Therapeutics, Inc.","startDate":"2015-12-22","conditions":"Peanut Allergy","enrollment":555},{"nctId":"NCT02371889","phase":"PHASE2","title":"A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2014-12-18","conditions":"Alcoholism, Alcohol Use Disorder (AUD)","enrollment":320},{"nctId":"NCT03353233","phase":"PHASE4","title":"Evaluation of Utility of Ultrasound Guided iPACK Block for Knee Extension After Total Knee Arthroplasty.","status":"COMPLETED","sponsor":"Duke University","startDate":"2018-05-03","conditions":"Knee Osteoarthritis, Primary Total Knee Arthroplasty, Physical Therapy","enrollment":50},{"nctId":"NCT01987817","phase":"PHASE2","title":"Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT","status":"COMPLETED","sponsor":"Aimmune Therapeutics, Inc.","startDate":"2014-02-06","conditions":"Peanut Allergy","enrollment":56},{"nctId":"NCT04248426","phase":"PHASE1","title":"A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection","status":"COMPLETED","sponsor":"Antios Therapeutics, Inc","startDate":"2020-02-05","conditions":"Hepatitis B, Chronic","enrollment":88},{"nctId":"NCT03201003","phase":"PHASE3","title":"ARTEMIS Peanut Allergy In Children","status":"COMPLETED","sponsor":"Aimmune Therapeutics, Inc.","startDate":"2017-06-12","conditions":"Peanut Allergy","enrollment":175},{"nctId":"NCT03524651","phase":"PHASE4","title":"Ferrous Acetyl-Aspartate Casein Formulation Evaluation Over Ferrous Sulfate in Iron Deficiency Anemia","status":"COMPLETED","sponsor":"Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.","startDate":"2018-05-02","conditions":"Iron Deficiency Anemia","enrollment":60},{"nctId":"NCT00483548","phase":"PHASE3","title":"Adjunctive Ziprasidone in the Treatment of Bipolar I Depression","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-10","conditions":"Bipolar Disorder, Depression, Bipolar","enrollment":298},{"nctId":"NCT03008889","phase":"PHASE2","title":"A Feasibility Study of N-acetylcysteine for Self-injurious Behavior in Children With Autism Spectrum Disorder","status":"COMPLETED","sponsor":"Emory University","startDate":"2018-07-05","conditions":"Autism Spectrum Disorder","enrollment":8},{"nctId":"NCT00919893","phase":"PHASE3","title":"Efficacy Study of a Standardized Pollen Extract Preparation (Cernilton) to Treat Inflammatory Chronic Prostatitis-Chronic Pelvic Pain Syndrome (CP-CPPS)","status":"COMPLETED","sponsor":"University of Giessen","startDate":"1999-12","conditions":"Chronic Prostatitis, Chronic Pelvic Pain Syndrome","enrollment":139},{"nctId":"NCT02853435","phase":"PHASE1","title":"To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-08-04","conditions":"Infections, Bacterial","enrollment":48},{"nctId":"NCT03030248","phase":"PHASE2","title":"Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2018-06-01","conditions":"Clostridium Difficile Infection, Hematologic Diseases, Bone Marrow Transplant","enrollment":9},{"nctId":"NCT04380025","phase":"NA","title":"Mirtogenol and Bimatoprost on IOP in Hispanics With Open-Angle Glaucoma","status":"UNKNOWN","sponsor":"University of Puerto Rico","startDate":"2020-05-15","conditions":"Glaucoma","enrollment":72},{"nctId":"NCT02753426","phase":"PHASE1","title":"A Trial of Doxycycline in Renal Disease","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2016-04","conditions":"Chronic Kidney Disease, Cardiorenal Syndrome","enrollment":11},{"nctId":"NCT00100165","phase":"PHASE2","title":"Phase 2 Trial of a Nicotinic Agonist in Schizophrenia","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2005-01","conditions":"Schizophrenia","enrollment":29},{"nctId":"NCT02104752","phase":"PHASE1, PHASE2","title":"Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia","status":"COMPLETED","sponsor":"VA Greater Los Angeles Healthcare System","startDate":"2014-07","conditions":"Schizophrenia, Cognition, Psychosis","enrollment":39},{"nctId":"NCT03720847","phase":"PHASE4","title":"Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2016-12-31","conditions":"Suicidal Ideation","enrollment":30},{"nctId":"NCT01628549","phase":"PHASE2","title":"Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Almirall, S.A.","startDate":"2012-06-30","conditions":"Acne Vulgaris","enrollment":285},{"nctId":"NCT00489255","phase":"PHASE4","title":"Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment","status":"COMPLETED","sponsor":"Ipsen","startDate":"2007-05","conditions":"Parkinson's Disease","enrollment":117},{"nctId":"NCT01500382","phase":"PHASE1","title":"A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-02-27","conditions":"Overactive Bladder, Overactive Urinary Bladder","enrollment":4},{"nctId":"NCT01989754","phase":"PHASE4","title":"A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2014-01-16","conditions":"Diabetes Mellitus, Type 2, Albuminuria","enrollment":5813}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Microcrystalline Cellulose (MCC), Placebo","Placebo, Sugar Pill","Symptom triggered benzodiazepines (e.g., Valium)","placebo","Placebo"],"phase":"marketed","status":"active","brandName":"Inactive Placebo Oral Capsule","genericName":"Inactive Placebo Oral Capsule","companyName":"Medical University of South Carolina","companyId":"medical-university-of-south-carolina","modality":"Small molecule","firstApprovalDate":"","aiSummary":"An inactive placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Clinical trial control / comparator (not a therapeutic indication).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}